Problems caused by regulatory delays and regulation

Glenn Pelikan

doi:10.1117/12.195460

6 December 1994 Problems caused by regulatory delays and regulation

Glenn Pelikan

Proceedings Volume 2307, Health Care Technology Policy I: The Role of Technology in the Cost of Health Care; (1994) https://doi.org/10.1117/12.195460
Event: The Role of Technology in the Cost of Health Care, 1994, Arlington, VA, United States

Abstract

The focus of FDA regulation on medical devices has changed substantially since its beginning in 1976. The earliest focus of GMP inspections was education of both the Industry and the Agency. Approval of new products through the 510K Premarket Notification process was generally achieved within the regulatory intended time of ninety days. Agency evaluation of 510K applications was focused on comparison to approved devices. All this has changed. The focus of GMP inspection today is enforcement. Sometimes that enforcement is targeted and sometimes it is arbitrary and capricious. Companies have been shut down and warning letters are now frequent. Some of this focus change has been warranted. Industry has been slow in its efforts to become fully GMP compliant. Approvals of 510K’s are taking much longer. The FDA’s backlog is now one year. The number of submissions has not grown substantially in the last few years, rather the process has become much slower. The amount of detail requested has, in some cases, exceeded any reasonable expectation I might have had. Current trends, if continued, represent a threat to an innovative and competitive Device Industry. Current trends are explored and changes recommended to bring about a better balance between the Agency and the Industry. The focus of FDA regulation on medical devices has changed substantially since its beginning in 1976. The earliest focus of GMP inspections was education of both the Industry and the Agency. Approval of new products through the 510K Premarket Notification process was generally achieved within the regulatory intended time of ninety days. Agency evaluation of 510K applications was focused on comparison to approved devices.

Citation Download Citation

Glenn Pelikan "Problems caused by regulatory delays and regulation", Proc. SPIE 2307, Health Care Technology Policy I: The Role of Technology in the Cost of Health Care, (6 December 1994); https://doi.org/10.1117/12.195460

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
4 PAGES

DOWNLOAD PAPER SAVE TO MY LIBRARY

GET CITATION

RIGHTS & PERMISSIONS

Get copyright permission Get copyright permission on Copyright Marketplace

KEYWORDS

Inspection

Manufacturing

Medicine

Safety

Medical devices

Calibration

Clinical trials

Show All Keywords

Keywords/Phrases

Search In:

Publication Years